A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
Conditions: Colorectal Cancer; Esophagus Cancer; Gastric Cancer; Pancreas Cancer; Non-small Cell Lung Cancer; Breast Cancer; Bile Duct Cancer Interventions: Biological: CEA-targeted CAR-T cells Sponsors: Chongqing Precision Biotech Co., Ltd; Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bile | Bile Duct Cancer | Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Clinical Trials | Colorectal Cancer | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Lung Cancer | Non-Small Cell Lung Cancer | Pancreas | Pancreatic Cancer | Research